A detailed history of Fmr LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 24,190 shares of CAPR stock, worth $163,282. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,190
Previous 24,756 2.29%
Holding current value
$163,282
Previous $234,000 2.56%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$6.34 - $14.23 $3,588 - $8,054
-566 Reduced 2.29%
24,190 $240,000
Q1 2025

May 12, 2025

BUY
$9.49 - $16.11 $9,006 - $15,288
949 Added 3.99%
24,756 $234,000
Q4 2024

Feb 13, 2025

SELL
$12.9 - $21.99 $6,927 - $11,808
-537 Reduced 2.21%
23,807 $329,000
Q3 2024

Nov 13, 2024

BUY
$3.56 - $15.21 $86,664 - $370,272
24,344 New
24,344 $370,000
Q1 2024

May 13, 2024

BUY
$3.61 - $6.88 $3 - $6
1 New
1 $0
Q4 2021

Feb 14, 2022

SELL
$2.89 - $4.16 $115 - $166
-40 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$3.16 - $5.72 $126 - $228
40 New
40 $0

Others Institutions Holding CAPR

About CAPRICOR THERAPEUTICS, INC.


  • Ticker CAPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,346,200
  • Market Cap $164M
  • Description
  • Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...
More about CAPR
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.